课题基金 / 基金详情

Role of Corticotropin Releasing Hormone in Intestinal Inflammation

Role of Corticotropin Releasing Hormone in Intestinal Inflammation
促肾上腺皮质激素释放激素在肠道炎症中的作用
批准号:
9118984
负责人:
CHARALABOS POTHOULAKIS
金额:
$34.65万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2018-07-31

项目摘要

项目成果

CHARALABOS POTHOULAKIS的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):促肾上腺皮质激素释放激素(CRH或CRF)是下丘脑促肾上腺皮质激素释放的主要调节因子。我们以前的研究表明,外周CRH及其家族成员Urocortin 2(Ucn 2)和Urocortin 3(Ucn 3)通过与CRH受体2(CRHR 2)结合并激活与结肠炎和IBD后粘膜愈合相关的重要途径(包括细胞增殖、迁移和伤口愈合)参与肠道炎症。本申请将测试CRHR 2激活通过与结肠上皮细胞和结肠成纤维细胞相互作用以刺激增殖、增强上皮伤口愈合、抑制细胞凋亡和刺激细胞因子和生长因子从人结肠成纤维细胞释放来协调结肠炎后粘膜愈合的新假设。还将检查功能性CRHR 2亚型CRHR 2 α、CRHR 2 β及其最近表征的可溶性小鼠切片变体sCRHR 2 α的作用。以下目标将解决这些假设。目的1将使用特异性CRHR 2受体拮抗剂CRHR 2-/-和肠上皮细胞特异性CRHR 2-/-(CRHR 2LoxP/LoxP)小鼠来确定CRHR 2及其配体CRH、Ucn 2和Ucn 3在结肠炎后粘膜愈合中的作用。目的2将检验CRHR 2激活刺激粘膜愈合重编程的假设,并研究所涉及的潜在信号通路,特别关注人结肠上皮细胞上的IL-6/STAT 3、Akt和EGFR通路。目的3将使用从CRHR 2-/-和肠上皮细胞特异性CRHR 2-/-小鼠分离的结肠成纤维细胞以及从IBD患者分离的人肠成纤维细胞来解决CRHR 2信号传导对人结肠成纤维细胞在粘膜愈合中的作用。这些研究将促进我们对IBD发病机制的理解,并确定CRH信号在这一重要疾病中的作用和机制。
英文摘要
 DESCRIPTION (provided by applicant): Corticotropin-releasing hormone (CRH or CRF) is the major hypothalamic regulator of ACTH release. Our previous studies showed that peripheral CRH and its family members Urocortin 2 (Ucn2) and Urocortin 3 (Ucn3) participate in intestinal inflammation by binding to CRH receptor 2 (CRHR2) and activating important pathways linked to mucosal healing following colitis and IBD, including cell proliferation, and migration and wound healing. This application will test the novel hypothesis that CRHR2 activation coordinates mucosal healing following colitis by interacting with colonic epithelial cells and colonic fibroblats to stimulate proliferation, enhance epithelial wound healing, inhibit apoptosis and stimulate release of cytokines and growth factors from human colonic fibroblasts. The role of the functional CRHR2 isoforms, CRHR2α, CRHR2β, and its recently characterized soluble mouse slice variant, sCRHR2α will also be examined. The following aims will address these hypotheses. Aim 1 will establish the role of CRHR2 and its ligands CRH, Ucn2 and Ucn3 in mucosal healing following colitis using specific CRHR2 receptor antagonists, CRHR2 -/- and intestinal epithelial cell specific CRHR2-/- (CRHR2LoxP/LoxP) mice. Aim 2 will examine the hypothesis that CRHR2 activation stimulates mucosal healing re-programming and investigate the underlying signaling pathways involved, with particular focus on the IL-6/STAT3, Akt and EGFR pathways on human colonic epithelial cells. Aim 3 will address the role of CRHR2 signaling on human colonic fibroblasts in mucosal healing using colonic fibroblasts isolated from CRHR2-/- and intestinal epithelial cell specific CRHR2-/- mice as well as human intestinal fibroblasts isolated from IBD patients. These studies should advance our understanding on the pathogenesis of IBD and define the role and mechanisms of CRH signaling in this important group of diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization and Targeting of MiR-24 Network in Colitis
Characterization and Targeting of MiR-24 Network in Colitis
Characterization and Targeting of MiR-24 Network in Colitis
Role of Corticotropin Releasing Hormone in Intestinal Inflammation
海外基金